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The power of synthetic biology for
bioproduction, remediation and
pollution control
The UN’s Sustainable Development Goals will inevitably require the application of molecular biology and
biotechnology on a global scale
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T he agenda of the UN’s SustainableDevelopment Goals (SDGs) [1] chal-lenges the synthetic biology
community—and the life sciences as a
whole—to develop transformative technolo-
gies that help to protect, even expand our
planet’s habitability. While modern tools
for genome editing already benefit applica-
tions in health and agriculture, sustainabil-
ity also asks for a dramatic transformation
of our use of natural resources. The chal-
lenge is not just to limit and, wherever
possible revert emissions of pollutants and
greenhouse gases, but also to replace envi-
ronmentally costly processes based on
fossil fuels with bio-based sustainable
alternatives. This task is not exclusively a
scientific and technical one but will also
require guidelines and regulations for the
development and large-scale deployment of
this new type of bio-based production.
Some recent advances that can (or soon
could) enable us to make progress in these
areas—and several possible governance
principles—need to be addressed.
The potential of biotechnology
The transformative power of modern,
science-based biotechnology that started in
the late 1970s has been accelerated by recent
developments, such as massive DNA
synthesis/sequencing, systems and synthetic
biology, and CRISPR tools for genome edit-
ing. The interface of these disciplines and
techniques with other flagship technologies
of the ongoing Fourth Industrial Revolution
[2], such as artificial intelligence, robotics,
big data, ITs, and so on, will usher in a soci-
ety, economy and industry that are very dif-
ferent from what we know today. So far,
market forces have pushed most research
efforts towards health-related issues and
agricultural productivity, as these areas can
more easily harvest low-hanging fruits of
contemporary systems-based biotechnology.
But the spectacular advances in biomedicine
and agricultural technologies are happening
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during an acute global environmental crisis
caused by overpopulation, loss of biodiver-
sity, greenhouse gas emissions and pollu-
tion. Thus, environmental sustainability is
at the core of the Sustainable Development
Goals (SDGs) proclaimed by the United
Nations [1] in 2015. One key aspect of this
pledge is the need to produce goods and
products in a way that is both economically
viable and ecologically sustainable.
However, reducing and eventually stopping
harmful emissions is not sufficient; it will
also require large-scale interventions to
restore ecological balances and remove
pollution by industrial and urban activities.
Given this background, what can and should
Biotechnology 4.0—biotechnology in the era
of the Fourth Industrial Revolution—do; in
particular, how could systems-guided meta-
bolic engineering and synthetic biology
contribute to sustainability goals?
Given the ongoing climate change and
the limits of fossil resources, bio-based
production of chemicals and materials from
renewable resources is becoming increas-
ingly important. While there are numerous
possible applications of engineered biologi-
cal systems, some of the most well-known
examples involve the rational design of
microbial hosts for the production of various
chemicals and materials. A good example is
the construction of yeast strains for the
production of the anti-malarial drug artemi-
sinin and opiates to provide a sustainable
supply that is unaffected by environmental
factors that could impact the plant source of
these drugs. More recently, the integration
of computational and experimental
approaches has enabled the generation of a
yeast strain that produces exceptionally high
yields of lipids as biofuel precursors. Even
non-natural chemicals, such as gasoline and
terephthalic acid, could be produced by
microbial metabolic engineering [3].
Evolution and design
Biology-by-design has also succeeded in
producing biomaterials including polysac-
charides, proteins, spider silk and diverse
polyhydroxyalkanoates (PHAs). For example,
Metabolic systems engineering
A
B
Chemical
modification 
• –COOH
• –OH
• Epoxide
• Aromatic
• –F, –Cl, –Br, –I, 
• –S–S–
• Amino acids
• Sugars
• Nucleotids
• Proteins
• Graphene, CNT
• PNIPAm
• PDMAEMA
• PEG
Homopolymers Randomcopolymers
Sea water
Simple, 
open and 
continuous 
fermentation
and
downstream
processes 
MICROBIAL POLYESTERS
Engineered Halomonas 
Block
copolymers
Functional/graft
copolymers
n
m2m1O O
O OR2R1
n2
m2m1
n1
O O
O OR2R1
nm
O
OR
n
m2m1O O
O O(CH2)x
CH2
CH
R1
©
 E
M
B
O
Figure 1. Bioplastic production.
(A) Polyhydroxyalkanoates (PHAs) and other polymers with diverse structures in the forms of homopolymers, random copolymers and block copolymers can be produced by
microorganisms developed by systems metabolic engineering. These polymers can be further chemically modified to make functional and graft copolymers. (B) Industrial
biotechnology based on extremophilic microorganisms (e.g., salt-loving Halomonas bacteria) could significantly reduce the manufacture cost of PHAs and other bioproducts.
2 of 6 EMBO reports e45658 | 2018 ª 2018 The Authors
EMBO reports Synthetic biology for sustainability Víctor de Lorenzo et al
Published online: March 26, 2018 
microorganisms have been successfully engi-
neered to efficiently produce PHAs, a family
of diverse biopolyesters, for environmentally
friendly packaging, medicine and smart mate-
rials (Fig 1). Beyond production of PHAs,
metabolic engineers have developed microbial
strains capable of producing even non-natural
materials such as poly(lactate-co-glycolate),
an FDA-approved biomedical polymer.
Processes and protocols for cultivating
industrial microorganisms in a bioreactor
are already well established but could be
further improved by exploring the physico-
chemical properties of natural organisms,
notably extremophilic bacteria. For example,
a salt-loving Halomonas strain that can grow
under high osmotic pressure and high pH
was recently engineered to produce chemi-
cals, biofuels and other valuable compounds
(Fig 1). It is now used to produce PHA
under unsterilized conditions using seawater
in open reactors made of ceramic, cement or
plastic, which helps to save energy, fresh
water and substrates. Similarly, environ-
mental bacteria that are able to thrive in
industrial sites with heavy chemical pollu-
tion became a treasure trove for research to
find both robust chassis, such as Pseu-
domonas putida, and catalytic activities that
can be used by the chemical industry [4].
One could then imagine developing a set
of designer microbes that can be deployed
as required to increase the range of
compounds that can be produced biologi-
cally to meet human needs—from medicines
to materials—or to remediate contaminants
in the environment. Increasing the range of
biological organisms that can be predictably
and reliably engineered along with the scale
of those engineering designs is a critical next
step towards fully realizing the potential of
bioproduction [5].
In silico tools for design
Several important developments are still
needed. These include an ability to rapidly
engineer existing organisms already
endowed with desirable phenotypic traits—
for instance, a higher tolerance for organic
solvents—as such complex phenotypes are
often difficult-to-impossible to transfer to
more tractable hosts. Additionally, under-
standing context dependence, such that engi-
neered genetic circuits can be readily
transferred to new biological frames while
performing up to the original specifications,
is essential to increase the speed of develop-
ing new workable chassis. Advances are also
needed in computational biology such that
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Figure 2. Advanced biotechnology for the environment.
Typical anthropogenic emissions and measures to manage them. (A) Industrial and urban activities generate molecules that impact negatively the functioning of the
biosphere. (B) The profile of an environmental pollutant is defined by the six parameters indicated, the outcome of which frames the bioremediation strategy. (C) Bio-based
approaches to tackle environmental pollution, from prevention to global-scale remediation. The direction of the arrow indicates the increasing complexity of the technologies.
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the behaviour of engineered biological
systems can be better predicted from the in
silico design.
......................................................
“. . . sustainability also asks
for a dramatic transformation
of our use of natural
resources.”
......................................................
Using mathematical modelling and
computer simulations, designers can test
system models for feasible system architec-
tures, optimal combinations of parameters,
or performance in regimes that would be
otherwise infeasible or too costly to test
in vitro. Mathematical models have been
essential for computer-aided design in
diverse areas, including molecular dynamics
simulations for drug design, constraint-
based models for metabolic engineering, and
process models for bioreactor control. Math-
ematical models are also valuable tools to
understand how gene circuits cause knock-
on effects on host physiology that could
disrupt the performance of implanted
devices. Model-guided design will become
increasingly important as synthetic biology
creates larger systems that interface gene
circuits with other cellular systems, such as
signalling networks and/or metabolic
networks. For example, dynamic metabolic
engineering models have revealed how
systems-level properties, such as metabolic
heterogeneity, can be controlled and even
exploited for biosynthesis. Furthermore,
new algorithms based on artificial intelli-
gence and rapidly increasing big (bio)data
will be needed to develop microbial cell
factories and to optimize bioprocesses. Such
advanced modelling and simulation can also
help to meet the challenge of scaling-up,
speeding-up and making large bioprocesses
more predictable—the main obstacles for
the still evident scepticism of the chemical
industry for bio-based manufacturing.
Dealing with waste and pollution
Contemporary biotechnology has not only
created new methods and processes to
produce molecules and materials. It has also
generated new approaches for managing,
sensing and remediating pollutants, includ-
ing the transformation of waste into value-
added molecules or energy. Unfortunately,
for now, the commercial worth of
environmental biotechnology is orders of
magnitude lower than its biomedical and
demand-driven counterparts. Yet, the
mounting evidence of climatic change
caused by industrial CO2 emissions and other
environmental calamities—water quality,
plastic waste in marine ecosystems and loss
of soluble phosphorus—increases the moti-
vation to tackle these challenges (Fig 2).
......................................................
“. . . how could systems-guided
metabolic engineering and
synthetic biology contribute to
sustainability goals?”
......................................................
One line of action is developing bio-based
alternatives to chemical processes that adopt
biocatalysts developed through metabolic
engineering, such as the production of
degradable plastics, biofuels and both bulk
and fine chemicals. These bio-based alterna-
tives are bound to capture a large portion of
the current market as oil becomes more
scarce and expensive. A second approach is
to reduce and prevent emissions of harmful
chemical waste at the point of manufactur-
ing. Microorganisms naturally possess a
considerable ability to degrade toxic mole-
cules that has been substantially enhanced
through directed evolution, genetic engineering
or a combination of both. The resulting bio-
catalysts can be integrated in zero-pollution
industrial pipelines. By the same token, a
number of CO2-fixing microorganisms—not
just cyanobacteria—and fermenters of highly
complex municipal, commercial, sludge or
agricultural biowaste can be genetically
enhanced (or entirely reinvented) for superior
performance to capture carbon in either
mineral or organic forms, thereby allowing
its conversion in value-added products like
sugars and polymers [6].
......................................................
“Increasing the range of
biological organisms that can
be predictably and reliably
engineered [. . .] is a critical
next step towards fully
realizing the potential of
bio-production.”
......................................................
Monitoring emissions of CO2 or other
pollutants with biosensing devices based on
the response of living cells to environmental
pollutants has proven and will continue to
be invaluable. Microorganisms are already
being used to monitor pollutant levels, such
as arsenic, in drinking water. When
combined with adequate detection hard-
ware, it is now possible to spot trinitro-
toluene (TNT) residues in soil left by
unexploded anti-personnel mines with engi-
neered bacteria [7]. Furthermore, extensive
bioremediation with biological agents,
including phytoremediation, can be
employed to remove pollutants from water
or soil below tolerable concentrations.
......................................................
“Model-guided design will
become increasingly important
as synthetic biology creates
larger systems that interface
gene circuits with other cellular
systems. . .”
......................................................
The ongoing emission of greenhouse
gases (CO2, CH4, N2O, chlorofluorocarbons
and hydrofluorocarbons) and the over-
whelming amount of microplastics in marine
ecosystems are among the most pressing
global challenges faced by our generation
and require interventions that go beyond
merely limiting emissions. The much-
debated geoengineering of planet Earth
could potentially be complemented or even
replaced by large-scale bioremediation
strategies to capture CO2 and to improve the
capacity of marine microorganisms to
degrade plastics in the environment.
Whether or not the public will accept such
unprecedented actions for handling emis-
sions, which are reminiscent of Terraform-
ing [8], remains to be seen (Fig 2).
Indecisiveness in view of such threats has
become one of the highest risks to develop-
ing a sustainable and lasting economy.
Governance and regulation
This, in fact, raises the issue of how to prop-
erly regulate and employ these new tech-
nologies for both bioproduction and
environmental management. Generally,
governance should reflect common, broadly
accepted values and build on existing bodies
that command widespread support. In
particular, we suggest two fundamental
touchstones: The UN’s Universal Declaration
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of Human Rights and the SDGs. The first
states that all persons are entitled to basic
rights and fundamental freedoms. As
already discussed, the second are a call for
action to meet the great challenges of our
time. As new biotechnologies and their
products emerge, a critical first step in eval-
uating these should include asking the
following two questions: Is this technology
in line with the Declaration of Human
Rights? Does it advance the SDGs?
......................................................
“The much-debated
geoengineering of planet Earth
could potentially be
complemented or even replaced
by large-scale bioremediation
strategies to capture CO2. . .”
......................................................
In seeking to reconcile conflicts and
tensions between fundamental values—as well
as regional or local values and preferences—
the principles of proportionality and non-
discrimination can provide helpful guidance.
Proportionality suggests for example that
safety requirements are proportionate to a
product’s safety or risk profile and should not
be disproportionately different to requirements
for products with comparable or even identical
safety profiles. A requirement to treat similar
things similarly, and to treat things differently
when there is a reasonable basis to do so, has
been established as the non-discrimination
principle in many legal traditions [9].
The so-called precautionary principle has
gained much attention in policy discussions
about the governance of new and emerging
technologies, although there is considerable
debate about its proper scope, content and
application in particular cases, especially
when food or the environment is at issue.
According to the EU Commission, the
precautionary principle requires that an
intervention must be proportionate, non-
discriminatory and consistent, among other
requirements, to achieve a balance between
protecting society against unacceptable risk
while not unnecessarily stifling innovation.
Even where diverse views around the
precautionary principle pertain, it is worth
bearing in mind earlier considerations in the
1970s by the first generation of scientists
working in the field of biotechnology who
emphasized the need for robust regulation
before moving into application, and the
Organisation for Economic Co-operation and
Development’s early guidance from the mid-
1980s to advance and assess step-by-step
and case-by-case [10].
......................................................
“In seeking to reconcile
conflicts and tensions between
fundamental values [. . .] the
principles of proportionality
and non-discrimination can
provide helpful guidance.”
......................................................
Given the enormous potential of biotech-
nology to help meet the SDGs and the contro-
versy some areas of biotechnology have
sparked, it is important to (re-)establish a
dialogue among all stakeholders to build and
expand mutual understanding and a culture
of trust between regulators, NGOs, scientists,
industry and the public, while remaining
respectful of established democratically legit-
imized administrative and judicial processes.
Such discussion should take into account
facts, feelings and value commitments, while
seeking to obtain a clear view of risks and
benefits. Only governance action that
embraces such multi-stakeholder discussions
will be recognized as fair, unbiased,
transparent and stable, which, ultimately,
will benefit individuals, communities and
society at large. Ensuring proper governance
is essential for realizing biotechnology’s
contributions to achieving the UN’s SDGs.
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